Publications by authors named "James D Berry"

Claim this Profile
P
Participation in U.S.-Based ALS Clinical Trials by Sex and Race.
Mark P Levine, Sun Young Chung, Kellen H Quigg, Judith Carey, Suma Babu, James D Berry

Muscle Nerve· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What can vowel acoustics reveal about the communicative participation of people living with ALS?
Abigail E Haenssler, June Okada, Marziye Eshghi, Alison Clark, Amrita Iyer, James D Berry

Amyotroph Lateral Scler Frontotemporal Degener· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial.
Michal Geva, Y Paul Goldberg, Melanie L Leitner, Andres Cruz-Herranz, Randal Hand, James D Berry

Amyotroph Lateral Scler Frontotemporal Degener· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design considerations for C9orf72 disease prevention trials.
Michael Benatar, Adam M Staffaroni, Joanne Wuu, Michael P McDermott, Melanie Quintana, James D Berry

Brain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral Sclerosis.
Brooke Krivickas, Erica Scirocco, Elisa Giacomelli, Saloni Sharma, Molly Benson, James D Berry

Muscle Nerve· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Troponin T in Tofersen-Treated SOD1 ALS Patients: Beginning to Resolve the Catch-22 of Identifying Treatment Responsive Biomarkers in ALS Drug Development.
James D Berry, Robert Bowser

Muscle Nerve· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis.
Tanner Michaelis, Cecilia S Lindestam Arlehamn, Emil Johansson, April Frazier, James D Berry

Nature· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical and clinical validation of step counting method in people living with amyotrophic lateral sclerosis.
Marcin Straczkiewicz, Katherine M Burke, Kendall T Carney, Narghes Calcagno, Sravan Mandepudi, James D Berry

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Clinical Experience With Sodium Phenylbutyrate and Taurursodiol at a Single Amyotrophic Lateral Sclerosis Center in the United States.
Narghes Calcagno, Erica Scirocco, Erin Clampffer, Grace Addy, Sean Morgan, James D Berry

Eur J Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large-Scale, Multi-Cohort Proteomic Study.
Oleksandr Dergai, Joanne Wuu, Magdalena Koziczak-Holbro, Andrea Malaspina, Volkan Granit, James D Berry

Ann Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Preliminary Investigation of Acoustic Features for Remote Monitoring of Respiration in ALS.
Kathryn P Connaghan, Marziye Eshghi, Abigail E Haenssler, Jordan R Green, Joycelyn Wang, James D Berry

Muscle Nerve· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial.
Brittney A Harkey, Sofia Distefano, Jaclyn A Pagliaro, Lindsay Heyd, Marianne Chase, James D Berry

Muscle Nerve· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construct Validity of the Amyotrophic Lateral Sclerosis Bulbar Dysfunction Index-Remote.
Timothy Pommée, Liziane Bouvier, Carolina Barnett-Tapia, Marc F Maffei, Sarah E Gutz, James D Berry

Am J Speech Lang Pathol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNM-Au8 in Amyotrophic Lateral Sclerosis-Reply.
James D Berry, Nicholas Maragakis, Sabrina Paganoni

JAMA· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliable monitoring of respiratory function with home spirometry in people living with amyotrophic lateral sclerosis.
Julián Peller, Marcos A Trevisan, Gaston Bujia, Felipe Aguirre, Diego E Shalom, James D Berry

Front Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma tau and phosphorylated tau at T181 are altered in amyotrophic lateral sclerosis.
Tiziana Petrozziello, Evan Mizerak, Aparna Krishnamoorthy, Rachel A Donahue, Ayleen L Castillo Torres, James D Berry

medRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Listener effort measures clinically meaningful change of dysarthria in amyotrophic lateral sclerosis.
Indu Navar Bingham, Raquel Norel, Esteban G Roitberg, Julián Peller, Marcos A Trevisan, James D Berry

Brain Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical assessment and interpretation of dysarthria in ALS using attention based deep learning AI models.
Michele Merler, Carla Agurto, Julian Peller, Esteban Roitberg, Alan Taitz, James D Berry

NPJ Digit Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis.
Adam N Trautwig, Edward J Fox, Eric B Dammer, Anantharaman Shantaraman, Lingyan Ping, James D Berry

Mol Neurodegener· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.

JAMA Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis.
Matija Zelic, Anna Blazier, Fabrizio Pontarelli, Michael LaMorte, Jeremy Huang, James D Berry

Immunity· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal muscle biomarkers of amyotrophic lateral sclerosis: a large-scale, multi-cohort proteomic study.
Oleksandr Dergai, Joanne Wuu, Magdalena Koziczak-Holbro, Andrea Malaspina, Volkan Granit, James D Berry

medRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal Digital Phenotyping of Behavior in a Neurology Clinic: Development of the Neurobooth Platform and the First Two Years of Data Collection.
Adonay S Nunes, Siddharth Patel, Brandon Oubre, Mainak Jas, Divya D Kulkarni, James D Berry

medRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis